Conformis, Inc. to Participate in Upcoming Investor Conferences
<!-- Name:DistributionId Value:8753821 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Conformis
Conformis Actera™ Hip System Receives 510(k) Clearance from the U.S. Food and Drug…
BILLERICA, Mass., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, today…
Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate…
BILLERICA, Mass., March 14, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Denise Pedulla has joined the Company as its Chief Legal Officer and Corporate…
Conformis, Inc. Announces Strong Clinical Study Results for Its Personalized Knee…
BILLERICA, Mass., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today the strong results of a published retrospective study of procedures using Conformis’…
Conformis, Inc. Announces First Procedure Performed Using the Identity Imprint™ Knee…
BILLERICA, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced the first procedure with the new Conformis Identity Imprint knee replacement system.…